Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms — ACET

Unruptured Intracranial Aneurysms Clinical Trial

Official title:
Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms

Status Completed

Clinical Trial Summary

Endovascular treatment of ruptured and unruptured intracranial aneurysms presents complications, mainly the thrombo-embolic complication. No specific studies have been conducted to study factors associated with the occurrence of thromboembolic complications (symptomatic or not) post endovascular treatment of intracranial aneurysms.

Clinical Trial Description

In this multicenter, prospective study, patients with treatment of unruptured intracranial aneurysms will be recruited. The thromboembolic complications will be research using diffusion-weighted MRI. ;

Study Design

Related Conditions & MeSH terms

Aneurysm
Intracranial Aneurysm
Unruptured Intracranial Aneurysms

Clinical Trial Details

NCT number	NCT02862756
Study type	Interventional
Source	CHU de Reims
Contact
Status	Completed
Phase	N/A
Start date	November 14, 2016
Completion date	March 9, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03063541` - Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms	Phase 3
Not yet recruiting	`NCT03462433` - Treatment of Ruptured Intracranial Aneurysms in China.
Completed	`NCT01490463` - Brain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms	N/A